Antonella Cosimati | Ricerc@Sapienza

Publications

Title	Published on	Year
73P Efficacy outcomes in ≥70-year-old or younger patients receiving regorafenib-to-trifluridine/tipiracil sequence or vice versa for refractory metastatic colorectal cancer: Findings from the multicenter retrospective “ReTrITA” study	ANNALS OF ONCOLOGY	2024
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study	CURRENT ONCOLOGY	2024
Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study	JOURNAL OF CLINICAL ONCOLOGY	2023
Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study	FRONTIERS IN PSYCHOLOGY	2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study	CURRENT ONCOLOGY	2023
Psoriasis induced by first‑line pembrolizumab in metastatic non‑small cell lung cancer: A case report	ONCOLOGY LETTERS	2023
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis	CANCERS	2023
P-195 Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study	ANNALS OF ONCOLOGY	2023
P-360 Efficacy of regorafenib according to extended RAS evaluation: A multicenter retrospective analysis	ANNALS OF ONCOLOGY	2023
P-368 Efficacacy of trifluridine/tipiracil according to extended RAS evaluation: A multicenter retrospective analysis	ANNALS OF ONCOLOGY	2023
Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!	EUROPEAN JOURNAL OF CANCER	2022
Comparative Analysis of Regorafenib and Trifluridine/Tipiracil in Later-Line Refractory Metastatic Colorectal Cancer: A Real-Life Multicenter Retrospective Study	TUMORI	2022
398P Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment	ANNALS OF ONCOLOGY	2022
Reply to the letter entitled: Re: The first report on Covid-19 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey	EUROPEAN JOURNAL OF CANCER	2021
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study	INTERNAL AND EMERGENCY MEDICINE	2018
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study	INTERNATIONAL JOURNAL OF CARDIOLOGY	2017